AI assistant
MACROGENICS INC — Director's Dealing 2016
Oct 5, 2016
34129_dirs_2016-10-05_fb687b7e-757d-492f-9d47-ba2cd3f4d1a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-10-03
Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-03 | Common Stock | M | 10000 | $4.70 | Acquired | 10000 | Direct |
| 2016-10-03 | Common Stock | S | 10000 | $29.34 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-10-03 | Employee Stock Option (right to buy) | $4.70 | M | 10000 | Disposed | 2023-07-18 | Common Stock (10000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2016.
F2: This transaction was executed in multiple trades at prices ranging from $28.755 to $29.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.